- 3
- 0
- 约3.65千字
- 约 7页
- 2017-09-10 发布于福建
- 举报
包载甲氨蝶呤聚乙交酯丙交酯纳米颗粒制备及体外释药机制探究
包载甲氨蝶呤聚乙交酯丙交酯纳米颗粒制备及体外释药机制探究
作者:郑明彬,龚萍,杨雪梅,吴喜仁,梅俊
【摘要】 目的制备包载甲氨蝶呤(MTX)的聚乙交酯丙交酯(PLGA)纳米颗粒并研究体外释药机制。方法采用溶剂挥发法制备包载MTX的PLGA纳米颗粒,对其形貌、大小进行表征,测定体外释药曲线,并采用药学模型进行拟合。结果纳米颗粒平均粒径为175.9nm,具有明显的缓释作用,释药行为最符合双相动力学方程。结论该研究为开发MTX的新剂型提供了实验依据。
【关键词】 甲氨蝶呤; 聚乙交酯丙交酯; 纳米颗粒; 拟合
Abstract:ObjectiveTo prepare methotrexate(MTX) loaded poly(lactic-co-glycolic) (PLGA) nanoparticles and investigate the mechanism on release in vitro.MethodsMTX-loaded nanoparticles were prepared by emulsion solvent evaporation method. The morphology and size of nanoparticles were studied, and in vitro release curve was measured. Moreover,
原创力文档

文档评论(0)